记者从浙江省公安厅获悉，浙江省日前下发了《关于进一步加强含麻黄碱复方制剂管理的通知》，要求自9月10日起，浙江省内药品零售企业在销售含麻黄碱类复方制剂时要登记购买人姓名、住址以及销售时间、名称、数量等信息。非处方药一次销售不得超过5个最小包装。

Reporters learned from the zhejiang province public security department，Zhejiang province has issued《On further strengthening ephedrine containing compound preparation management notice》，Requirements since September 10，Zhejiang province drug retail enterprises in the sales contain ephedrine kind of compound preparation to register the name of the purchaser、Address and selling time、name、Number information。Otc drug a sale may not exceed 5 minimum packaging。

　　记者从浙江省公安厅禁毒总队了解到，近年来，随着我国易制毒化学品管理工作力度加强，境内外不法分子在难以获得制作冰毒原料麻黄素的情况下，开始用合法的含有麻黄碱的复方药品来替代麻黄素。这些境内外不法分子相互勾结，在我国内陆省区套购、骗购麻黄碱类复方药品，然后运送到云南边境，伺机走私出境。之后，境外贩毒分子从这些麻黄碱类复方药品中提取麻黄碱后制造冰毒，然后走私贩运到我国。

Reporters from the drug corps of zhejiang province public security department to know，In recent years，Along with our country precursor chemicals management efforts，Both at home and abroad, lawless elements in difficult to obtain making methamphetamine raw material under the condition of ephedrine，Begin to use legal ephedrine containing the compound drugs instead of ephedrine。And these outlaws collusion with each other，In our country inland provinces arbitrage in、Illegal drug ephedrine kind of compound，And then shipped to yunnan border，Bided smuggling exit。after，Overseas drug molecules from these ephedrine kind of compound drug ephedrine extract after manufacture methamphetamine，Then smuggling traffic in our country。

　　浙江禁毒总队有关负责人表示，浙江省医药、化工、交通运输、进出口贸易发达，省内生产、经营、使用易制毒化学品品种全面，涉及易制毒化学品企业众多。受当前国际国内制毒犯罪严峻形势的影响，易制毒化学品面临巨大流失风险，易制毒化学品管制工作面临严峻挑战。

Zhejiang anti-drug corps relevant person in charge said，Zhejiang pharmaceutical、chemical、transportation、Import and export trade developed，Province production、business、Use of precursor chemicals varieties comprehensive，Involving precursor chemicals enterprise many。By the current international and domestic situation influence such crime，Precursor chemicals are faced with great loss risk，Precursor chemicals control work faces severe challenges。

　　为加强批发经营等购销管理，《通知》要求药品生产企业和药品批发企业销售含麻黄碱类复方制剂时，建立购买方客户档案，严格审核购买方资质证明材料，对采购人员身份证明进行核查，防止含麻黄碱类复方制剂流入非法渠道。当药品经营企业、医疗机构购买完成后，需向公安、药监等部门进行购买记录登记。同时要求零售企业建立销售登记表，如实登记购买人姓名、住址以及销售药品时间、名称、数量等信息。(记者 方列)

In order to strengthen wholesale business and marketing management，《notice》For pharmaceutical production enterprise and drug wholesale enterprise sales contain ephedrine class when of compound preparations，Build customer file the purchaser，Audit strictly the purchaser qualification proof material，Proof of identity to purchasing personnel checks，Prevent contain ephedrine kind of compound preparation into illegal channels。When drug-handling enterprise、After the completion of medical institutions to purchase，Need to the public security、Also and other departments to buy record registration。At the same time the requirement retail enterprises to establish sales registration form，The name of the purchaser registered according to the facts、Address and selling drugs time、name、Number information。(Reporter square column)